PELI1
Basic information
Region (hg38): 2:64092652-64144420
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PELI1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 26 | 26 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 26 | 0 | 0 |
Variants in PELI1
This is a list of pathogenic ClinVar variants found in the PELI1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-64094742-T-C | not specified | Uncertain significance (Aug 13, 2021) | ||
2-64094760-T-C | not specified | Uncertain significance (May 02, 2024) | ||
2-64094761-G-A | not specified | Uncertain significance (Aug 02, 2021) | ||
2-64094793-T-C | not specified | Uncertain significance (Aug 07, 2024) | ||
2-64094871-G-A | not specified | Uncertain significance (Apr 06, 2024) | ||
2-64094887-C-T | not specified | Uncertain significance (Mar 06, 2025) | ||
2-64094890-C-T | not specified | Uncertain significance (Jan 09, 2024) | ||
2-64094982-C-T | not specified | Uncertain significance (Jul 02, 2024) | ||
2-64094992-T-G | not specified | Uncertain significance (Aug 05, 2024) | ||
2-64095064-C-A | not specified | Uncertain significance (Oct 17, 2023) | ||
2-64095070-T-G | not specified | Uncertain significance (Aug 04, 2023) | ||
2-64095166-C-G | not specified | Uncertain significance (Feb 27, 2023) | ||
2-64095171-G-A | not specified | Uncertain significance (Mar 06, 2023) | ||
2-64095175-T-G | not specified | Uncertain significance (Sep 14, 2022) | ||
2-64095177-T-C | not specified | Uncertain significance (Jan 27, 2022) | ||
2-64095261-A-T | not specified | Uncertain significance (Aug 05, 2024) | ||
2-64095268-C-T | not specified | Uncertain significance (Dec 06, 2023) | ||
2-64096231-T-C | not specified | Uncertain significance (Mar 14, 2023) | ||
2-64096240-T-C | not specified | Uncertain significance (Sep 26, 2024) | ||
2-64096488-T-C | not specified | Uncertain significance (Nov 11, 2024) | ||
2-64096526-C-T | not specified | Uncertain significance (Dec 14, 2023) | ||
2-64096591-C-T | not specified | Uncertain significance (Oct 19, 2024) | ||
2-64100454-G-A | not specified | Uncertain significance (Jun 02, 2023) | ||
2-64100462-G-A | not specified | Uncertain significance (Feb 27, 2024) | ||
2-64100496-T-C | not specified | Uncertain significance (Jan 26, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PELI1 | protein_coding | protein_coding | ENST00000358912 | 6 | 51803 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.390 | 0.609 | 125735 | 0 | 10 | 125745 | 0.0000398 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.12 | 149 | 242 | 0.617 | 0.0000132 | 2740 |
Missense in Polyphen | 44 | 99.222 | 0.44345 | 1061 | ||
Synonymous | -1.06 | 98 | 85.6 | 1.15 | 0.00000484 | 811 |
Loss of Function | 3.06 | 4 | 18.0 | 0.222 | 8.61e-7 | 223 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000119 | 0.000119 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000264 | 0.0000264 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000663 | 0.0000653 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: E3 ubiquitin ligase catalyzing the covalent attachment of ubiquitin moieties onto substrate proteins. Involved in the TLR and IL-1 signaling pathways via interaction with the complex containing IRAK kinases and TRAF6. Mediates 'Lys-63'-linked polyubiquitination of IRAK1 allowing subsequent NF-kappa-B activation (PubMed:12496252, PubMed:17675297). Mediates 'Lys-48'- linked polyubiquitination of RIPK3 leading to its subsequent proteasome-dependent degradation; preferentially recognizes and mediates the degradation of the 'Thr-182' phosphorylated form of RIPK3 (PubMed:29883609). Negatively regulates necroptosis by reducing RIPK3 expression (PubMed:29883609). Mediates 'Lys-63'- linked ubiquitination of RIPK1 (PubMed:29883609). {ECO:0000269|PubMed:12496252, ECO:0000269|PubMed:17675297, ECO:0000269|PubMed:29883609}.;
- Pathway
- Regulation of toll-like receptor signaling pathway;IL-1 signaling pathway;Toll Like Receptor 7/8 (TLR7/8) Cascade;Signaling by Interleukins;Cytokine Signaling in Immune system;Toll Like Receptor 9 (TLR9) Cascade;MyD88 cascade initiated on plasma membrane;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll-Like Receptors Cascades;Interleukin-1 signaling;IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation;Innate Immune System;Immune System;IL1;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;Toll Like Receptor 4 (TLR4) Cascade;IRAK1 recruits IKK complex;MyD88:Mal cascade initiated on plasma membrane;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Toll Like Receptor 2 (TLR2) Cascade;Interleukin-1 family signaling
(Consensus)
Recessive Scores
- pRec
- 0.128
Intolerance Scores
- loftool
- 0.337
- rvis_EVS
- -0.49
- rvis_percentile_EVS
- 22.09
Haploinsufficiency Scores
- pHI
- 0.864
- hipred
- Y
- hipred_score
- 0.775
- ghis
- 0.592
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.976
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Peli1
- Phenotype
- endocrine/exocrine gland phenotype; cellular phenotype; homeostasis/metabolism phenotype; immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; digestive/alimentary phenotype;
Gene ontology
- Biological process
- protein polyubiquitination;positive regulation of cytokine production;protein phosphorylation;Toll signaling pathway;positive regulation of B cell proliferation;positive regulation of protein ubiquitination;negative regulation of NF-kappaB transcription factor activity;response to lipopolysaccharide;positive regulation of toll-like receptor 3 signaling pathway;positive regulation of toll-like receptor 4 signaling pathway;negative regulation of T cell proliferation;positive regulation of I-kappaB kinase/NF-kappaB signaling;proteasome-mediated ubiquitin-dependent protein catabolic process;response to dsRNA;negative regulation of necroptotic process;interleukin-1-mediated signaling pathway;protein K63-linked ubiquitination;protein K48-linked ubiquitination
- Cellular component
- nucleus;cytosol
- Molecular function
- protein serine/threonine kinase activity;protein binding;ubiquitin-ubiquitin ligase activity;ubiquitin protein ligase activity